Overview

Detailed Summary

Artemis Hospitals operates as a leading multi-speciality healthcare provider located in Gurugram, India, offering a wide range of medical services. They aim to increase their total bed capacity significantly to 2,300 beds by 2029 through strategic expansions, including new hospital setups. Artemis Hospitals has achieved substantial growth in international patient revenue, contributing significantly to total revenue, reflecting its strong positioning in medical tourism.
The hospital is recognized for its advanced technological adoption, including the use of AI-assisted triage systems and cutting-edge medical equipment like Da Vinci® Robotic Surgical System. This technological edge supports enhanced patient care and operational efficiency.
Artemis Hospitals enjoys substantial growth in patient volume, with increased focus on high-value procedures that reflect rising demand for specialized healthcare services. Its international patient revenue has seen growth due to the hospital's global reputation for advanced medical care.

Sector: Healthcare Services
Industry: Hospital
Market Cap: 3,640 Cr
Volatility: Low Risk
P/E Ratio: 41.2
Industry P/E: 55.2
PEG Ratio: 0.8
P/B Ratio: 3.2
52W High: 297.70
52W Low: 202.85

Sales CAGR

1Y: 6.64%
3Y: 18.79%
5Y: 10.15%
10Y: 9.55%

Profit CAGR

1Y: 67.24%
3Y: 36.83%
5Y: 32.51%
10Y: 16.18%

ROE

TTM: 10.76%
3Y: 10.14%
5Y: 8.89%
10Y: 9.10%

ROCE

TTM: 13.34%
3Y: 11.91%
5Y: 10.46%
10Y: 11.31%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Healthcare Healthcare Healthcare Services Hospital

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
KOVAI		5180.55	5,945 Cr	97.76	4.99	0.18	19.21	21.31	12.30
INDRAMEDCO		428.00	3,893 Cr	21.45	5.91	1.06	26.54	34.84	19.17
ARTEMISMED		227.40	3,640 Cr	41.18	3.18	0.17	10.76	13.34	6.76
DRAGARWQ		4840.00	2,342 Cr	33.24	7.45	0.12	20.02	14.77	9.58
SHALBY		144.70	1,724 Cr	380.79	1.72	0.00	0.45	6.06	0.23
KMCSHIL		83.69	1,453 Cr	37.53	7.98	0.00	16.69	19.54	12.23
GPTHEALTH		129.40	1,060 Cr	24.79	5.35	2.71	26.36	23.95	0.00
Median: 7 Co.	—	227.40	2,342 Cr	37.53	5.35	0.17	19.21	19.54	9.58

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	225	219	225	223	241	232	240	255	275	272
Expenses	191	186	187	187	199	195	204	214	224	228
Operating Profit	34	33	38	36	42	37	36	41	51	45
OPM %	15.20	14.92	16.85	16.21	17.50	16.12	14.96	16.24	18.42	16.36
Other Income	2.42	1.78	1.90	4.40	7.44	8.80	12	6.93	7.65	4.39
Interest	7.88	7.96	8.57	8.13	7.98	8.00	7.83	7.38	7.19	6.75
Depreciation	9.95	10	11	11	11	11	12	11	12	12
Profit Before Tax	19	16	20	22	31	27	29	30	39	30
Tax %	27.98	29.18	29.30	23.61	27.56	23.16	20.03	28.84	23.79	25.29
Net Profit	14	12	14	17	22	21	23	21	30	22
EPS in Rs	0.84	0.71	0.88	0.97	1.23	1.14	1.26	1.18	1.67	1.41

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	547	565	408	555	737	879	937	969
Expenses	483	504	373	487	643	746	785	812
Operating Profit	64	61	35	67	94	133	152	157
OPM %	11.68	10.88	8.62	12.16	12.74	15.10	16.20	16.21
Other Income	4.00	4.60	6.77	3.90	7.34	7.35	33	36
Interest	11	13	13	12	20	31	32	31
Depreciation	20	23	22	22	31	40	45	46
Profit Before Tax	37	31	7.53	37	51	68	108	116
Tax %	44.51	36.47	18.20	15.55	24.89	28.21	23.67	25.00
Net Profit	20	19	6.16	31	38	49	82	87
EPS in Rs	—	8.16	0.41	1.91	2.35	3.04	4.59	5.52
Dividend Payout %	0.00	0.00	0.00	0.00	16.13	12.75	8.47	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	13	13	13	13	13	14	14
Reserves	280	300	307	346	390	435	824
Borrowings	91	92	147	201	286	320	290
Other Liabilities	170	181	133	149	216	203	229
Total Liabilities	554	586	600	710	905	972	1,357
Fixed Assets	381	393	383	489	605	719	745
CWIP	49	56	81	64	95	33	40
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	124	137	136	157	205	219	572
Total Assets	554	586	600	710	905	972	1,357

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	40	56	27	60	127	109	146
Cash from Investing Activity	-50	-26	-37	-107	-158	-87	-385
Cash from Financing Activity	14	-27	18	44	38	-30	267
Net Cash Flow	5.30	2.37	7.55	-3.46	7.17	-8.26	27

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Nov 2025	Dec 2025	Mar 2026
Promoters	68.03%	68.03%	68.03%	67.51%	67.17%	67.17%	67.17%	66.53%	66.53%	58.43%	58.39%	58.39%
FIIs	0.09%	0.11%	0.10%	0.16%	0.22%	0.64%	0.31%	0.24%	0.37%	12.48%	12.47%	12.19%
DIIs	8.69%	9.13%	9.78%	10.57%	10.69%	11.59%	12.13%	11.78%	11.29%	9.51%	9.07%	9.05%
Public	23.18%	22.72%	22.08%	21.76%	21.92%	20.60%	20.39%	21.46%	21.81%	19.58%	20.08%	20.37%
Total Shareholders	20,529	22,375	19,993	19,795	26,054	27,003	28,397	31,614	33,559	31,884	31,602	32,044

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan